BR112017019176A2 - processos para a preparação de fluorocetolídeos - Google Patents

processos para a preparação de fluorocetolídeos

Info

Publication number
BR112017019176A2
BR112017019176A2 BR112017019176A BR112017019176A BR112017019176A2 BR 112017019176 A2 BR112017019176 A2 BR 112017019176A2 BR 112017019176 A BR112017019176 A BR 112017019176A BR 112017019176 A BR112017019176 A BR 112017019176A BR 112017019176 A2 BR112017019176 A2 BR 112017019176A2
Authority
BR
Brazil
Prior art keywords
preparation
fluorocetolides
processes
fluorocetolide
intermediates
Prior art date
Application number
BR112017019176A
Other languages
English (en)
Portuguese (pt)
Inventor
Eugene Pereira David
Deo Keshav
e schneider Stephen
Original Assignee
Cempra Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cempra Pharmaceuticals Inc filed Critical Cempra Pharmaceuticals Inc
Publication of BR112017019176A2 publication Critical patent/BR112017019176A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
BR112017019176A 2015-03-06 2016-03-05 processos para a preparação de fluorocetolídeos BR112017019176A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562129305P 2015-03-06 2015-03-06
PCT/US2016/021085 WO2016144833A1 (en) 2015-03-06 2016-03-05 Processes for preparing fluoroketolides

Publications (1)

Publication Number Publication Date
BR112017019176A2 true BR112017019176A2 (pt) 2018-04-24

Family

ID=56880477

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017019176A BR112017019176A2 (pt) 2015-03-06 2016-03-05 processos para a preparação de fluorocetolídeos

Country Status (19)

Country Link
US (2) US20180044365A1 (enExample)
EP (1) EP3265100A4 (enExample)
JP (1) JP6773672B2 (enExample)
KR (1) KR20170133377A (enExample)
CN (1) CN107405355A (enExample)
AU (1) AU2016230027A1 (enExample)
BR (1) BR112017019176A2 (enExample)
CA (1) CA2978731A1 (enExample)
CL (1) CL2017002255A1 (enExample)
CO (1) CO2017010143A2 (enExample)
HK (1) HK1247097A1 (enExample)
IL (1) IL254306A0 (enExample)
MX (2) MX2017011454A (enExample)
PE (1) PE20180219A1 (enExample)
RU (1) RU2017131253A (enExample)
SG (2) SG10201908248PA (enExample)
TW (1) TW201638102A (enExample)
WO (1) WO2016144833A1 (enExample)
ZA (1) ZA201706505B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668282A (en) * 1970-05-08 1972-06-06 Stauffer Chemical Co Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides
CA2529817C (en) * 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7595300B2 (en) * 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
AU2008316830B2 (en) * 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8376805B2 (en) * 2008-07-24 2013-02-19 Ideo Llc Printable pre-sewn stuffed toy composite sheets
WO2012117357A2 (en) * 2011-03-01 2012-09-07 Wockhardt Limited Process for preparation of ketolide intermediates
EP2968801B1 (en) * 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
MX356772B (es) * 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.
CN105246334A (zh) * 2013-04-04 2016-01-13 哈佛大学的校长及成员们 大环内酯及其制备和使用方法

Also Published As

Publication number Publication date
EP3265100A4 (en) 2019-01-09
WO2016144833A1 (en) 2016-09-15
HK1247097A1 (zh) 2018-09-21
MX2017011454A (es) 2018-01-23
TW201638102A (zh) 2016-11-01
IL254306A0 (en) 2017-11-30
US20180044365A1 (en) 2018-02-15
KR20170133377A (ko) 2017-12-05
CO2017010143A2 (es) 2018-02-28
RU2017131253A (ru) 2019-04-08
US20210070797A1 (en) 2021-03-11
SG10201908248PA (en) 2019-10-30
ZA201706505B (en) 2021-04-28
MX2020007742A (es) 2020-09-25
SG11201707215XA (en) 2017-10-30
JP6773672B2 (ja) 2020-10-21
CA2978731A1 (en) 2016-09-15
CN107405355A (zh) 2017-11-28
EP3265100A1 (en) 2018-01-10
PE20180219A1 (es) 2018-01-31
CL2017002255A1 (es) 2018-05-11
AU2016230027A1 (en) 2017-09-28
JP2018508537A (ja) 2018-03-29

Similar Documents

Publication Publication Date Title
CL2016001871A1 (es) Anticuerpos humanos para pd-1
PL3519420T3 (pl) Cykliczne związki dinukleotydowe
EP3436867A4 (en) HEAD-MOUNTED DISPLAY TRACKING
EA201891211A1 (ru) Ингибиторы cxcr2
MX2017015464A (es) Anticuerpos anti-tau y metodos de uso.
IL264143B (en) Processes for preparing olaparib
EA201790984A1 (ru) Анти-cd79b антитела и способы их применения
EP3307739A4 (en) NRF2-REGULATORS
HUE059158T2 (hu) Eljárás pridopidin elõállítására
MX2016010433A (es) Anticuerpos anti-jagged1 y metodos de uso.
BR112017013568A2 (pt) compostos bicíclicos fundidos para o tratamento de doenças
MA49639A (fr) Polymorphes de 5-fluoro-4-imino-3-méthyl-1-tosyl-3,4-dihydropyrimidin-2-one
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
DK3558961T3 (da) Polymorfer
DK3558995T3 (da) Polymorfer
EP3307702A4 (en) CHEMICAL P62 ZZ HEMMER
IL268683A (en) Processes for preparing ag-10, its intermediates, and salts thereof
MX383748B (es) Procesos para la preparación de un compuesto de diariltiohidantoína.
PT3728208T (pt) Polimorfos
BR112017019176A2 (pt) processos para a preparação de fluorocetolídeos
CO2017010621A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
IL271388B (en) Improved process for preparing imetelstat
MX380240B (es) Preparación de piperidin-4-carbotioamida.
EP3699601A4 (en) REACTION PROCESS

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]